Home - Dylan Jovine

Free Report:

 The 1 Question Bitcoin “Experts” Can’t Answer

READ NOW

The Biggest Opportunity in Takeovers Today

Jul 11, 2019

There’s a huge merger wave happening in the biotech industry. And it’s not because of any deregulation out of Washington. It’s because of good, old-fashioned survival.

More >> More >>

How to Invest in Biotech Stocks

Jun 13, 2019

The stocks we recommend at Biotech Insider are in either the start-up phase or the growth phase of their life cycle.

By nature that means these investments are high-risk, high-return investments. It also means they’re going to be very volatile. Sometimes comically volatile.

That’s why most professional investors look at small cap biotech investing like venture capital investing. And just like venture capital investing, fortunes can be made even when you know in advance that you will lose money on a good portion of the investments you make.

In fact, let me just say right now that here at Biotech Insider we expect 30% of the investments we make to lose money.

More >> More >>

All of Wall Street Says to Buy Uber. We Take a Look…

Jun 06, 2019

25 Analysts Started Coverage of Uber. None of Them Think the Stock is a Sell. We Take a Look.

More >> More >>
MORE >>